One such tissue is the liver, where DOCK5 activity increases energy expenditure and insulin signaling by impeding mammalian target of rapamycin complex (mTORC1), linking DOCK5 downregulation to obesity (93). This evidence concerns the gene DOCK5 and obesity due to melanocortin 4 receptor deficiency.